ID   ZJU-0826
AC   CVCL_XE04
DR   CCRID; 4201PAT-CCTCC01128
DR   Wikidata; Q98136531
RX   Patent=CN108048401A;
RX   PubMed=31359275;
RX   PubMed=35640676;
CC   Group: Patented cell line.
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017175.
CC   Population: Chinese.
CC   Doubling time: 63.84 hours (PubMed=31359275).
CC   Karyotypic information: Near triploid karyotype (PubMed=31359275).
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=31359275
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 8,12
ST   D16S539: 9,11,12,13
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9,10
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 10
//
RX   Patent=CN108048401A;
RA   Sun J.-H., Yang X.-M., Zhou F., Zhang Y.-H.;
RT   "Human biliary tract cancer cell lines and application.";
RL   Patent number CN108048401A, 18-May-2018.
//
RX   PubMed=31359275; DOI=10.1245/s10434-019-07649-5;
RA   Zhang Y.-H., Luo J.-F., Dong X., Yang F., Zhang M.-F., Zhao J.-J.,
RA   Wang Q.-F., Zhou F., Sun J.-H., Yang X.-M.;
RT   "Establishment and characterization of two novel cholangiocarcinoma
RT   cell lines.";
RL   Ann. Surg. Oncol. 26:4134-4147(2019).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//